Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis
NCT ID: NCT00373568
Last Updated: 2010-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
25 participants
INTERVENTIONAL
2005-04-30
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Miltefosine for Mucosal Leishmaniasis
NCT00373776
Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia
NCT00233545
Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis
NCT03829917
Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis with Inhaled Pentamidine Plus Oral Miltefosine
NCT06550609
Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia
NCT00537953
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
miltefosine: 2.5 mg/kg/day for 42 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
12 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AB Foundation
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jaime Soto, MD
Role: PRINCIPAL_INVESTIGATOR
CIBIC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Palos Blancos
Palos Blancos, , Bolivia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
05--01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.